Cargando…
What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
BACKGROUND: Tocilizumab, an interleukin-6 receptor blocker, has been used in the inflammatory phase of COVID-19, but its impact independent of corticosteroids remains unclear in patients with severe disease. METHODS: In this retrospective analysis of patients with COVID-19 admitted between March 2 a...
Autores principales: | Mehta, Monica, Purpura, Lawrence J., McConville, Thomas H., Neidell, Matthew J., Anderson, Michaela R., Bernstein, Elana J., Dietz, Donald E., Laracy, Justin, Gunaratne, Shauna H., Miller, Emily Happy, Cheng, Jennifer, Zucker, Jason, Shah, Shivang S., Chaudhuri, Shaoli, Gordillo, Christian A., Patel, Shreena R., Guo, Tai Wei, Karaaslan, Lara E., Reshef, Ran, Miko, Benjamin A., Bathon, Joan M., Pereira, Marcus R., Uhlemann, Anne-Catrin, Yin, Michael T., Sobieszczyk, Magdalena E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8031323/ https://www.ncbi.nlm.nih.gov/pubmed/33831046 http://dx.doi.org/10.1371/journal.pone.0249349 |
Ejemplares similares
-
Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019
por: May, Michael, et al.
Publicado: (2021) -
371. Cluster of carbapenemase-producing Enterobacterales secondary infections during the COVID-19 crisis at a New York City hospital
por: Gomez-Simmonds, Angela, et al.
Publicado: (2020) -
Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections
por: Kubin, Christine J, et al.
Publicado: (2021) -
476. Increased Depression and Anxiety Associated with COVID-19 among Recipients of HIV Healthcare Services at Sexual Health Clinic in NYC
por: Huang, Simian, et al.
Publicado: (2023) -
An efficient and versatile CRISPR-Cas9 system for genetic manipulation of multi-drug resistant Klebsiella pneumoniae
por: McConville, Thomas H., et al.
Publicado: (2021)